The estimated Net Worth of John L Miclot is at least 1.97 百万$ dollars as of 28 February 2020. Mr. Miclot owns over 10,309 units of Wright Medical NV stock worth over 1,662,091$ and over the last 17 years he sold WMGI stock worth over 0$. In addition, he makes 304,965$ as Non-Executive Independent Director at Wright Medical NV.
John has made over 7 trades of the Wright Medical NV stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 10,309 units of WMGI stock worth 183,706$ on 28 February 2020.
The largest trade he's ever made was exercising 20,618 units of Wright Medical NV stock on 6 March 2017 worth over 450,709$. On average, John trades about 984 units every 28 days since 2007. As of 28 February 2020 he still owns at least 55,440 units of Wright Medical NV stock.
You can see the complete history of Mr. Miclot stock trades at the bottom of the page.
John L. Miclot serves as Non-Executive Independent Director of the Company. Mr. Miclot was a member of the board of directors of Wright Medical Group, Inc. from 2007 to 2015. Mr. Miclot has served as President and Chief Executive Officer and a member of the board of directors of LinguaFlex, Inc., a medical device company focused on treatment of sleep disordered breathing, since August 2015. From December 2011 to December 2014, he served as Chief Executive Officer and a member of the board of directors of Tengion Inc., a publicly held company that focused on organ and cell regeneration. Prior to joining Tengion, Mr. Miclot was an Executive-in Residence at Warburg Pincus, LLC. From 2008 to 2010, he was President and Chief Executive Officer of CCS Medical, Inc., a provider of products and services for patients with chronic diseases. From 2003 until 2008, he served as President and Chief Executive Officer of Respironics, Inc., a provider of sleep and respiratory products, and prior to such time, served in various positions at Respironics, Inc. from 1998 to 2003, including Chief Strategic Officer and President of the Homecare Division. From 1995 to 1998, he served as Senior Vice President, Sales and Marketing of Healthdyne Technologies, Inc., a medical device company that was acquired by Respironics, Inc. in 1998. Mr. Miclot spent the early part of his medical career at DeRoyal Industries, Inc., Baxter International Inc., Ohmeda Medical, Inc. and Medix Inc. Mr. Miclot serves as a director of the Pittsburgh Zoo and PPG Aquarium, charitable and educational institutions, serves on the University of Iowa Tippie College of Business board of advisors and serves as an industrial advisor to EQT Partners, an investment company.
As the Non-Executive Independent Director of Wright Medical NV, the total compensation of John Miclot at Wright Medical NV is 304,965$. There are 11 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of 7,309,180$.
John Miclot is 61, he's been the Non-Executive Independent Director of Wright Medical NV since 2015. There are 7 older and 16 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
John's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Over the last 9 years, insiders at Wright Medical NV have traded over 526,674,381$ worth of Wright Medical NV stock and bought 118,654 units worth 2,654,459$ . The most active insiders traders include Sean Carney、Elizabeth H Weatherman、Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of 4,402,563$. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth 28,644$.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: